Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

1.1K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.1K
Standard Precaution01:26

Standard Precaution

2.1K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.1K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

2.8K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.8K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

31
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

3.9K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
3.9K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.4K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heart failure with mildly reduced ejection fraction (HFmrEF): where are we now?

Heart failure reviews·2026
Same author

Precision Medicine for Anticoagulation Strategies in the Cath Lab: Part 1.

Current cardiology reports·2026
Same author

Clinical Updates in Pulmonary Hypertension.

Reviews in cardiovascular medicine·2026
Same author

Current Advances and Navigating the Complexities of SVG-PCI.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

The American journal of medicine·2026
Same author

Financial Toxicity: Inequities and Impact on Cardiovascular Disease.

Arteriosclerosis, thrombosis, and vascular biology·2026

Related Experiment Video

Updated: Aug 27, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.3K

COVID-19 and preventive strategy.

Chayakrit Krittanawong1,2,3, Neil Maitra1,2, Anirudh Kumar4

  • 1Section of Cardiology, Baylor College of Medicine Houston, TX, USA.

American Journal of Cardiovascular Disease
|September 23, 2022
PubMed
Summary
This summary is machine-generated.

The COVID-19 pandemic, caused by SARS-CoV-2, has led to millions of deaths globally. This review summarizes COVID-19 epidemiology, transmission, clinical presentation, and therapies to propose a preventive strategy.

Keywords:
COVID-19preventive strategy

More Related Videos

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

4.9K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

2.9K

Related Experiment Videos

Last Updated: Aug 27, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.3K
Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

4.9K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

2.9K

Area of Science:

  • * Infectious Diseases and Epidemiology
  • * Virology and Public Health

Background:

  • * The novel coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, emerged in December 2019, rapidly escalating into a global pandemic.
  • * COVID-19 has surpassed previous epidemics like SARS and MERS in terms of mortality and global impact, with over 293 million cases and 5.4 million deaths reported by January 2022.
  • * While often presenting with mild symptoms, COVID-19 poses a significant risk of severe disease and death in individuals with pre-existing comorbidities.

Purpose of the Study:

  • * To review and synthesize peer-reviewed and preprint literature on COVID-19.
  • * To summarize the epidemiology, transmission, and clinical presentation of COVID-19.
  • * To discuss available therapies and propose a comprehensive preventive strategy to combat the pandemic.

Main Methods:

  • * Comprehensive literature review of peer-reviewed articles and preprints.
  • * Analysis of epidemiological data, transmission dynamics, and clinical characteristics.
  • * Evaluation of current and investigational therapeutic agents for COVID-19.

Main Results:

  • * COVID-19 exhibits high pathogenicity and contagiousness, necessitating urgent public health interventions such as quarantining and social distancing.
  • * A wide range of therapeutic strategies, including novel agents and repurposed medications, are under investigation.
  • * Effective pandemic mitigation requires a collaborative effort involving healthcare providers, health systems, patients, private sectors, and governments.

Conclusions:

  • * A multi-faceted approach combining public health measures, therapeutic advancements, and inter-sectoral collaboration is essential for overcoming the COVID-19 pandemic.
  • * Continued research and evidence synthesis are crucial for refining preventive and therapeutic strategies.
  • * Protecting both healthcare providers and patients is paramount in the ongoing global health crisis.